BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33306333)

  • 1. Covid-19 scientific publications from Turkey.
    Çiftçiler R; Haznedaroğlu İC; Tufan A; Öztürk MA
    Turk J Med Sci; 2021 Jun; 51(3):. PubMed ID: 33306333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LitCovid: an open database of COVID-19 literature.
    Chen Q; Allot A; Lu Z
    Nucleic Acids Res; 2021 Jan; 49(D1):D1534-D1540. PubMed ID: 33166392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
    Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M
    Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Coronavirus Pandemic: What Does the Evidence Show?
    Paudel S; Dangal G; Chalise A; Bhandari TR; Dangal O
    J Nepal Health Res Counc; 2020 Apr; 18(1):1-9. PubMed ID: 32335585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
    Vargas M; Servillo G; Einav S
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Publishing research during pandemics: are you vulnerable to the COVID-19 or predatory publishers?
    Memon AR; Rathore FA
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S166-S168. PubMed ID: 32515402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biological Data Mining and Machine Learning Techniques in Detecting and Diagnosing the Novel Coronavirus (COVID-19): A Systematic Review.
    Albahri AS; Hamid RA; Alwan JK; Al-Qays ZT; Zaidan AA; Zaidan BB; Albahri AOS; AlAmoodi AH; Khlaf JM; Almahdi EM; Thabet E; Hadi SM; Mohammed KI; Alsalem MA; Al-Obaidi JR; Madhloom HT
    J Med Syst; 2020 May; 44(7):122. PubMed ID: 32451808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronaviruses - a new old menace.
    Golke A; Piekarska K; Dzieciątkowski T
    Postepy Biochem; 2020 Dec; 66(4):303-308. PubMed ID: 33470077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel unorthodox strategies to reduce the case fatality rate of COVID-19 in high risk groups.
    Hlavaty T; Krajcovicova A
    Bratisl Lek Listy; 2020; 121(7):462-465. PubMed ID: 32989996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
    Lian N; Xie H; Lin S; Huang J; Zhao J; Lin Q
    Clin Microbiol Infect; 2020 Jul; 26(7):917-921. PubMed ID: 32344167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten challenging questions about SARS-CoV-2 and COVID-19.
    Teymoori-Rad M; Samadizadeh S; Tabarraei A; Moradi A; Shahbaz MB; Tahamtan A
    Expert Rev Respir Med; 2020 Sep; 14(9):881-888. PubMed ID: 32536226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic.
    Mandal H
    Turk J Med Sci; 2020 Apr; 50(SI-1):485-488. PubMed ID: 32299208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients.
    TaŞtan C; Yurtsever B; Sir KarakuŞ G; Dİlek KanÇaĞi D; Demİr S; Abanuz S; Seyİs U; Yildirim M; Kuzay R; Elİbol Ö; Arbak S; AÇikel Elmas M; BİrdoĞan S; Sezerman OU; KocagÖz AS; YalÇin K; Ovali E
    Turk J Biol; 2020; 44(3):192-202. PubMed ID: 32595356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.